[FG] Niess Jan
Publications
62 found
Show per page
Marinucci, Mattia (2025) Molecular and metabolic dynamics in cancer: therapeutic insights for metastatic colorectal cancer and hepatocellular carcinoma. Doctoral Thesis. University of Basel.
Marinucci, Mattia (2025) Molecular and metabolic dynamics in cancer: therapeutic insights for metastatic colorectal cancer and hepatocellular carcinoma. Doctoral Thesis. University of Basel.
Ebrahimi, Ramin et al. (2025) ‘Increased Risk of Cardiovascular Events After Coronary Interventions in Inflammatory Bowel Disease: A Nationwide Matched Cohort Study’, Alimentary Pharmacology and Therapeutics [Preprint]. Available at: https://doi.org/10.1111/apt.70162.
Ebrahimi, Ramin et al. (2025) ‘Increased Risk of Cardiovascular Events After Coronary Interventions in Inflammatory Bowel Disease: A Nationwide Matched Cohort Study’, Alimentary Pharmacology and Therapeutics [Preprint]. Available at: https://doi.org/10.1111/apt.70162.
Woelfel, Simon et al. (2025) ‘XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease’, Alimentary Pharmacology and Therapeutics, 61(2), pp. 299–312. Available at: https://doi.org/10.1111/apt.18349.
Woelfel, Simon et al. (2025) ‘XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease’, Alimentary Pharmacology and Therapeutics, 61(2), pp. 299–312. Available at: https://doi.org/10.1111/apt.18349.
Woelfel, S. et al. (2024) ‘STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease’, Vaccines, 12(11), p. 1241. Available at: https://doi.org/10.3390/vaccines12111241.
Woelfel, S. et al. (2024) ‘STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease’, Vaccines, 12(11), p. 1241. Available at: https://doi.org/10.3390/vaccines12111241.
Rubin, D.T. et al. (2024) ‘Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative Colitis’, Inflammatory Bowel Diseases [Preprint]. Available at: https://doi.org/10.1093/ibd/izae204.
Rubin, D.T. et al. (2024) ‘Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative Colitis’, Inflammatory Bowel Diseases [Preprint]. Available at: https://doi.org/10.1093/ibd/izae204.
Byndloss, Mariana et al. (2024) ‘The gut microbiota and diabetes: research, translation, and clinical applications – 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum’, Diabetologia. 24.06.2024, 67(9), pp. 1760–1782. Available at: https://doi.org/10.1007/s00125-024-06198-1.
Byndloss, Mariana et al. (2024) ‘The gut microbiota and diabetes: research, translation, and clinical applications – 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum’, Diabetologia. 24.06.2024, 67(9), pp. 1760–1782. Available at: https://doi.org/10.1007/s00125-024-06198-1.
Byndloss, Mariana et al. (2024) ‘The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications—2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum’, Diabetes, 73(9), pp. 1391–1410. Available at: https://doi.org/10.2337/dbi24-0028.
Byndloss, Mariana et al. (2024) ‘The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications—2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum’, Diabetes, 73(9), pp. 1391–1410. Available at: https://doi.org/10.2337/dbi24-0028.
Byndloss, Mariana et al. (2024) ‘The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications—2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum’, Diabetes Care, 47(9), pp. 1491–1508. Available at: https://doi.org/10.2337/dci24-0052.
Byndloss, Mariana et al. (2024) ‘The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications—2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum’, Diabetes Care, 47(9), pp. 1491–1508. Available at: https://doi.org/10.2337/dci24-0052.
Melhem, H. and Niess, J.H. (2024) ‘Eosinophilic Esophagitis and Inflammatory Bowel Disease: What Are the Differences?’, International Journal of Molecular Sciences, 25(15), p. 8534. Available at: https://doi.org/10.3390/ijms25158534.
Melhem, H. and Niess, J.H. (2024) ‘Eosinophilic Esophagitis and Inflammatory Bowel Disease: What Are the Differences?’, International Journal of Molecular Sciences, 25(15), p. 8534. Available at: https://doi.org/10.3390/ijms25158534.
Wakim El-Khoury, Jeanine et al. (2024) ‘Cohort Profile Update: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)’, Inflammatory Intestinal Diseases, 9(1), pp. 165–173. Available at: https://doi.org/10.1159/000539713.
Wakim El-Khoury, Jeanine et al. (2024) ‘Cohort Profile Update: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)’, Inflammatory Intestinal Diseases, 9(1), pp. 165–173. Available at: https://doi.org/10.1159/000539713.
Woelfel, S. et al. (2024) ‘Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease’, Vaccines, 12(7), p. 774. Available at: https://doi.org/10.3390/vaccines12070774.
Woelfel, S. et al. (2024) ‘Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease’, Vaccines, 12(7), p. 774. Available at: https://doi.org/10.3390/vaccines12070774.
Kaymak, Tanay and Niess, Jan Hendrik (2024) ‘Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis’, Journal of Visualized Experiments , 2024(207). Available at: https://doi.org/10.3791/66503.
Kaymak, Tanay and Niess, Jan Hendrik (2024) ‘Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis’, Journal of Visualized Experiments , 2024(207). Available at: https://doi.org/10.3791/66503.
Baldrich, Adrian et al. (2024) ‘Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency’, Journal of Clinical Immunology, 44(3). Available at: https://doi.org/10.1007/s10875-024-01667-z.
Baldrich, Adrian et al. (2024) ‘Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency’, Journal of Clinical Immunology, 44(3). Available at: https://doi.org/10.1007/s10875-024-01667-z.
Göldi, Andreas et al. (2024) ‘Noninvasive Disease Assessment in Eosinophilic Esophagitis With Fractionated Exhaled Nitric Oxide, Blood, and Fecal Biomarkers’, Journal of Clinical Gastroenterology [Preprint]. Available at: https://doi.org/10.1097/MCG.0000000000002068.
Göldi, Andreas et al. (2024) ‘Noninvasive Disease Assessment in Eosinophilic Esophagitis With Fractionated Exhaled Nitric Oxide, Blood, and Fecal Biomarkers’, Journal of Clinical Gastroenterology [Preprint]. Available at: https://doi.org/10.1097/MCG.0000000000002068.
Lehmann, Anouk et al. (2024) ‘Risankizumab and Certolizumab Pegol Dual-Targeted Therapy for Crohn’s Disease and Axial Spondyloarthritis: A Case Report’, Case Reports in Gastroenterology, pp. 22–30. Available at: https://doi.org/10.1159/000542759.
Lehmann, Anouk et al. (2024) ‘Risankizumab and Certolizumab Pegol Dual-Targeted Therapy for Crohn’s Disease and Axial Spondyloarthritis: A Case Report’, Case Reports in Gastroenterology, pp. 22–30. Available at: https://doi.org/10.1159/000542759.
Miyamoto K et al. (2023) ‘The gut microbiota-induced kynurenic acid recruits GPR35-positive macrophages to promote experimental encephalitis’, Cell Reports, 42(8), p. 113005. Available at: https://doi.org/10.1016/j.celrep.2023.113005.
Miyamoto K et al. (2023) ‘The gut microbiota-induced kynurenic acid recruits GPR35-positive macrophages to promote experimental encephalitis’, Cell Reports, 42(8), p. 113005. Available at: https://doi.org/10.1016/j.celrep.2023.113005.
Kaymak, Tanay et al. (2023) ‘IL-20 subfamily cytokines impair the oesophageal epithelial barrier by diminishing filaggrin in eosinophilic oesophagitis’, Gut, 72(5), pp. 821–833. Available at: https://doi.org/10.1136/gutjnl-2022-327166.
Kaymak, Tanay et al. (2023) ‘IL-20 subfamily cytokines impair the oesophageal epithelial barrier by diminishing filaggrin in eosinophilic oesophagitis’, Gut, 72(5), pp. 821–833. Available at: https://doi.org/10.1136/gutjnl-2022-327166.
Rohm, Theresa V. et al. (2022) ‘Targeting colonic macrophages improves glycemic control in high-fat diet-induced obesity’, Communications Biology, 5(1). Available at: https://doi.org/10.1038/s42003-022-03305-z.
Rohm, Theresa V. et al. (2022) ‘Targeting colonic macrophages improves glycemic control in high-fat diet-induced obesity’, Communications Biology, 5(1). Available at: https://doi.org/10.1038/s42003-022-03305-z.
Serra, Eva Gonçalves et al. (2022) ‘Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (Nature Communications, (2020), 11, 1, (995), 10.1038/s41467-019-14275-y)’, Nature Communications , 13(1). Available at: https://doi.org/10.1038/s41467-022-31010-2.
Serra, Eva Gonçalves et al. (2022) ‘Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (Nature Communications, (2020), 11, 1, (995), 10.1038/s41467-019-14275-y)’, Nature Communications , 13(1). Available at: https://doi.org/10.1038/s41467-022-31010-2.
Jordi, Sebastian Bruno Ulrich et al. (2022) ‘The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients’, Journal of Gastroenterology, 57(11), pp. 848–866. Available at: https://doi.org/10.1007/s00535-022-01902-7.
Jordi, Sebastian Bruno Ulrich et al. (2022) ‘The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients’, Journal of Gastroenterology, 57(11), pp. 848–866. Available at: https://doi.org/10.1007/s00535-022-01902-7.
Casadó-Llombart S et al. (2022) ‘Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease’, Frontiers in Immunology, 13, p. 966184. Available at: https://doi.org/10.3389/fimmu.2022.966184.
Casadó-Llombart S et al. (2022) ‘Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease’, Frontiers in Immunology, 13, p. 966184. Available at: https://doi.org/10.3389/fimmu.2022.966184.
Kaymak T, Hruz P and Niess JH (2022) ‘Immune system and microbiome in the esophagus: implications for understanding inflammatory diseases’, FEBS Journal, 289(16), pp. 4758–4772. Available at: https://doi.org/10.1111/febs.16103.
Kaymak T, Hruz P and Niess JH (2022) ‘Immune system and microbiome in the esophagus: implications for understanding inflammatory diseases’, FEBS Journal, 289(16), pp. 4758–4772. Available at: https://doi.org/10.1111/febs.16103.
Müller A et al. (2022) ‘[The IBD-Control questionnaire: German translation and validation of the standardized questionnaire for Patient Reported Outcome Measurement in inflammatory bowel disease].’, Zeitschrift fur Gastroenterologie, 60(6), pp. 911–926. Available at: https://doi.org/10.1055/a-1482-8642.
Müller A et al. (2022) ‘[The IBD-Control questionnaire: German translation and validation of the standardized questionnaire for Patient Reported Outcome Measurement in inflammatory bowel disease].’, Zeitschrift fur Gastroenterologie, 60(6), pp. 911–926. Available at: https://doi.org/10.1055/a-1482-8642.
Melhem, Hassan et al. (2022) ‘Epithelial GPR35 protects from Citrobacter rodentium infection by preserving goblet cells and mucosal barrier integrity’, Mucosal Immunology, 15(3), pp. 443–458. Available at: https://doi.org/10.1038/s41385-022-00494-y.
Melhem, Hassan et al. (2022) ‘Epithelial GPR35 protects from Citrobacter rodentium infection by preserving goblet cells and mucosal barrier integrity’, Mucosal Immunology, 15(3), pp. 443–458. Available at: https://doi.org/10.1038/s41385-022-00494-y.
Walldorf J et al. (2022) ‘The Selective 5-HT1A Agonist SR57746A Protects Intestinal Epithelial Cells and Enteric Glia Cells and Promotes Mucosal Recovery in Experimental Colitis’, Inflammatory Bowel Diseases, 28(3), pp. 423–433. Available at: https://doi.org/10.1093/ibd/izab191.
Walldorf J et al. (2022) ‘The Selective 5-HT1A Agonist SR57746A Protects Intestinal Epithelial Cells and Enteric Glia Cells and Promotes Mucosal Recovery in Experimental Colitis’, Inflammatory Bowel Diseases, 28(3), pp. 423–433. Available at: https://doi.org/10.1093/ibd/izab191.
Lett, Martin J et al. (2022) ‘Stimulatory MAIT cell antigens reach the circulation and are efficiently metabolised and presented by human liver cells’, Gut, 71(12), pp. 2526–2538. Available at: https://doi.org/10.1136/gutjnl-2021-324478.
Lett, Martin J et al. (2022) ‘Stimulatory MAIT cell antigens reach the circulation and are efficiently metabolised and presented by human liver cells’, Gut, 71(12), pp. 2526–2538. Available at: https://doi.org/10.1136/gutjnl-2021-324478.
Melhem H, Regan-Komito D and Niess JH (2021) ‘Mucins dynamics in physiological and pathological conditions’, International Journal of Molecular Sciences, 22(24). Available at: https://doi.org/10.3390/ijms222413642.
Melhem H, Regan-Komito D and Niess JH (2021) ‘Mucins dynamics in physiological and pathological conditions’, International Journal of Molecular Sciences, 22(24). Available at: https://doi.org/10.3390/ijms222413642.
Kaya B, Melhem H and Niess JH (2021) ‘GPR35 in Intestinal Diseases: From Risk Gene to Function’, Frontiers in Immunology, 12, p. 717392. Available at: https://doi.org/10.3389/fimmu.2021.717392.
Kaya B, Melhem H and Niess JH (2021) ‘GPR35 in Intestinal Diseases: From Risk Gene to Function’, Frontiers in Immunology, 12, p. 717392. Available at: https://doi.org/10.3389/fimmu.2021.717392.
Sutter M, Hruz P and Niess JH (2021) ‘High Serum Creatine Kinase Levels in Infliximab and Vedolizumab-Treated Inflammatory Bowel Disease Patients’, Inflammatory Intestinal Diseases, 6(3), pp. 165–174. Available at: https://doi.org/10.1159/000518264.
Sutter M, Hruz P and Niess JH (2021) ‘High Serum Creatine Kinase Levels in Infliximab and Vedolizumab-Treated Inflammatory Bowel Disease Patients’, Inflammatory Intestinal Diseases, 6(3), pp. 165–174. Available at: https://doi.org/10.1159/000518264.
Jordi S.B.U. et al. (2021) ‘Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel disease’, Alimentary Pharmacology and Therapeutics, 54(1), pp. 53–67. Available at: https://doi.org/10.1111/apt.16365.
Jordi S.B.U. et al. (2021) ‘Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel disease’, Alimentary Pharmacology and Therapeutics, 54(1), pp. 53–67. Available at: https://doi.org/10.1111/apt.16365.
Rohm TV et al. (2021) ‘Obesity in Humans Is Characterized by Gut Inflammation as Shown by Pro-Inflammatory Intestinal Macrophage Accumulation’, Frontiers in Immunology, 12, p. 668654. Available at: https://doi.org/10.3389/fimmu.2021.668654.
Rohm TV et al. (2021) ‘Obesity in Humans Is Characterized by Gut Inflammation as Shown by Pro-Inflammatory Intestinal Macrophage Accumulation’, Frontiers in Immunology, 12, p. 668654. Available at: https://doi.org/10.3389/fimmu.2021.668654.
Herrema H and Niess JH (2020) ‘Intestinal microbial metabolites in human metabolism and type 2 diabetes’, Diabetologia, 63(12), pp. 2533–2547. Available at: https://doi.org/10.1007/s00125-020-05268-4.
Herrema H and Niess JH (2020) ‘Intestinal microbial metabolites in human metabolism and type 2 diabetes’, Diabetologia, 63(12), pp. 2533–2547. Available at: https://doi.org/10.1007/s00125-020-05268-4.
Serra E.G. et al. (2020) ‘Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease’, Nature Communications, 11(1). Available at: https://doi.org/10.1038/s41467-019-14275-y.
Serra E.G. et al. (2020) ‘Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease’, Nature Communications, 11(1). Available at: https://doi.org/10.1038/s41467-019-14275-y.
Kaya B et al. (2020) ‘Lysophosphatidic Acid-Mediated GPR35 Signaling in CX3CR1+ Macrophages Regulates Intestinal Homeostasis’, Cell Reports, 32(5), p. 107979. Available at: https://doi.org/10.1016/j.celrep.2020.107979.
Kaya B et al. (2020) ‘Lysophosphatidic Acid-Mediated GPR35 Signaling in CX3CR1+ Macrophages Regulates Intestinal Homeostasis’, Cell Reports, 32(5), p. 107979. Available at: https://doi.org/10.1016/j.celrep.2020.107979.
Rybinski F et al. (2020) ‘Amoebic Liver Abscess in Crohn Disease Treated with Ustekinumab’, Inflammatory Bowel Diseases. Oxford University Press, 26(7). Available at: https://doi.org/10.1093/ibd/izaa101.
Rybinski F et al. (2020) ‘Amoebic Liver Abscess in Crohn Disease Treated with Ustekinumab’, Inflammatory Bowel Diseases. Oxford University Press, 26(7). Available at: https://doi.org/10.1093/ibd/izaa101.
Schneider T et al. (2020) ‘The copper/zinc ratio correlates with markers of disease activity in patients with inflammatory bowel disease’, Crohn’s and Colitis 360, 2(1), p. otaa001. Available at: https://doi.org/10.1093/crocol/otaa001.
Schneider T et al. (2020) ‘The copper/zinc ratio correlates with markers of disease activity in patients with inflammatory bowel disease’, Crohn’s and Colitis 360, 2(1), p. otaa001. Available at: https://doi.org/10.1093/crocol/otaa001.
Melhem H et al. (2019) ‘Metabolite-sensing G protein-coupled receptors connect the diet-microbiota-metabolites axis to inflammatory bowel disease’, Cells, 8(5). Available at: https://doi.org/10.3390/cells8050450.
Melhem H et al. (2019) ‘Metabolite-sensing G protein-coupled receptors connect the diet-microbiota-metabolites axis to inflammatory bowel disease’, Cells, 8(5). Available at: https://doi.org/10.3390/cells8050450.
Niess JH and Francés R (2019) ‘Editorial: The IL-20 cytokines and related family members in immunity and diseases’, Frontiers in Immunology. Frontiers Media S.A.info@frontiersin.org, 10(AUG). Available at: https://doi.org/10.3389/fimmu.2019.01976.
Niess JH and Francés R (2019) ‘Editorial: The IL-20 cytokines and related family members in immunity and diseases’, Frontiers in Immunology. Frontiers Media S.A.info@frontiersin.org, 10(AUG). Available at: https://doi.org/10.3389/fimmu.2019.01976.
Niess JH, Kaymak T and Hruz P (2019) ‘[The Role of the Exposome in the Emergence of Chronic Inflammatory Bowel Diseases].’, Therapeutische Umschau. Revue therapeutique, 75(5), pp. 261–270. Available at: https://doi.org/10.1024/0040-5930/a000998.
Niess JH, Kaymak T and Hruz P (2019) ‘[The Role of the Exposome in the Emergence of Chronic Inflammatory Bowel Diseases].’, Therapeutische Umschau. Revue therapeutique, 75(5), pp. 261–270. Available at: https://doi.org/10.1024/0040-5930/a000998.
Pillai, Nadia et al. (2019) ‘Evaluating the cost-effectiveness of early compared to late or no biologic treatment to manage Crohn’s disease using real world data’, Journal of Crohn’s & colitis, 14(4), pp. 490–500. Available at: https://doi.org/10.1093/ecco-jcc/jjz169.
Pillai, Nadia et al. (2019) ‘Evaluating the cost-effectiveness of early compared to late or no biologic treatment to manage Crohn’s disease using real world data’, Journal of Crohn’s & colitis, 14(4), pp. 490–500. Available at: https://doi.org/10.1093/ecco-jcc/jjz169.
Radulovic K et al. (2019) ‘NLRP6 deficiency in CD4 T cells decreases T cell survival associated with increased cell death’, Journal of Immunology, 203(2), pp. 544–556. Available at: https://doi.org/10.4049/jimmunol.1800938.
Radulovic K et al. (2019) ‘NLRP6 deficiency in CD4 T cells decreases T cell survival associated with increased cell death’, Journal of Immunology, 203(2), pp. 544–556. Available at: https://doi.org/10.4049/jimmunol.1800938.
Caviezel D et al. (2018) ‘High Prevalence of Vitamin D Deficiency among Patients with Inflammatory Bowel Disease’, Inflammatory Intestinal Diseases. 28.06.2018, 2(4), pp. 200–210. Available at: https://doi.org/10.1159/000489010.
Caviezel D et al. (2018) ‘High Prevalence of Vitamin D Deficiency among Patients with Inflammatory Bowel Disease’, Inflammatory Intestinal Diseases. 28.06.2018, 2(4), pp. 200–210. Available at: https://doi.org/10.1159/000489010.
Niess JH, Hruz P and Kaymak T (2018) ‘The Interleukin-20 cytokines in intestinal diseases’, Frontiers in Immunology, 9(JUN), p. 1373. Available at: https://doi.org/10.3389/fimmu.2018.01373.
Niess JH, Hruz P and Kaymak T (2018) ‘The Interleukin-20 cytokines in intestinal diseases’, Frontiers in Immunology, 9(JUN), p. 1373. Available at: https://doi.org/10.3389/fimmu.2018.01373.
Raduolovic K et al. (2018) ‘Injections of lipopolysaccharide into mice to mimic entrance of microbial-derived products after intestinal barrier breach’, Journal of Visualized Experiments. Journal of Visualized ExperimentsMoshe.Pritsker@JoVE.com, 2018(135). Available at: https://doi.org/10.3791/57610.
Raduolovic K et al. (2018) ‘Injections of lipopolysaccharide into mice to mimic entrance of microbial-derived products after intestinal barrier breach’, Journal of Visualized Experiments. Journal of Visualized ExperimentsMoshe.Pritsker@JoVE.com, 2018(135). Available at: https://doi.org/10.3791/57610.
Kaymak T et al. (2018) ‘Low Discontinuation Rate of Infliximab Treatment in Steroid-Dependent/Refractory Crohn’s Disease Patients’, Inflammatory Intestinal Diseases. 21.02.2018, 2(3), pp. 171–179. Available at: https://doi.org/10.1159/000486676.
Kaymak T et al. (2018) ‘Low Discontinuation Rate of Infliximab Treatment in Steroid-Dependent/Refractory Crohn’s Disease Patients’, Inflammatory Intestinal Diseases. 21.02.2018, 2(3), pp. 171–179. Available at: https://doi.org/10.1159/000486676.
Piñero P et al. (2017) ‘IL26 modulates cytokine response and anti-TNF consumption in Crohn’s disease patients with bacterial DNA’, Journal of Molecular Medicine. 06.09.2017, 95(11), pp. 1227–1236. Available at: https://doi.org/10.1007/s00109-017-1585-6.
Piñero P et al. (2017) ‘IL26 modulates cytokine response and anti-TNF consumption in Crohn’s disease patients with bacterial DNA’, Journal of Molecular Medicine. 06.09.2017, 95(11), pp. 1227–1236. Available at: https://doi.org/10.1007/s00109-017-1585-6.
Steinert A et al. (2017) ‘The stimulation of macrophages with TLR ligands supports increased IL-19 expression in inflammatory bowel disease patients and in colitis models’, Journal of Immunology. 01.09.2017, 199(7), pp. 2570–2584. Available at: https://doi.org/10.4049/jimmunol.1700350.
Steinert A et al. (2017) ‘The stimulation of macrophages with TLR ligands supports increased IL-19 expression in inflammatory bowel disease patients and in colitis models’, Journal of Immunology. 01.09.2017, 199(7), pp. 2570–2584. Available at: https://doi.org/10.4049/jimmunol.1700350.
Pittet, Valerie et al. (2017) ‘Patient self-reported concerns in inflammatory bowel diseases: A genderspecific subjective quality-of-life indicator’, PLoS ONE, 12(2). Available at: https://doi.org/10.1371/journal.pone.0171864.
Pittet, Valerie et al. (2017) ‘Patient self-reported concerns in inflammatory bowel diseases: A genderspecific subjective quality-of-life indicator’, PLoS ONE, 12(2). Available at: https://doi.org/10.1371/journal.pone.0171864.
Dawson, H. et al. (2016) ‘Macroscopy predicts tumor progression in gastric cancer: A retrospective patho-historical analysis based on Napoleon Bonaparte’s autopsy report’, Digestive and Liver Disease, 48(11), pp. 1378–1385. Available at: https://doi.org/10.1016/j.dld.2016.07.013.
Dawson, H. et al. (2016) ‘Macroscopy predicts tumor progression in gastric cancer: A retrospective patho-historical analysis based on Napoleon Bonaparte’s autopsy report’, Digestive and Liver Disease, 48(11), pp. 1378–1385. Available at: https://doi.org/10.1016/j.dld.2016.07.013.
Heimgartner, B. et al. (2016) ‘Successful Treatment of Small Intestinal Bleeding in a Crohn’s Patient with Noncirrhotic Portal Hypertension by Transjugular Portosystemic Shunt Placement and Infliximab Treatment’, Case Reports in Gastroenterology, 10(3), pp. 589–595. Available at: https://doi.org/10.1159/000450541.
Heimgartner, B. et al. (2016) ‘Successful Treatment of Small Intestinal Bleeding in a Crohn’s Patient with Noncirrhotic Portal Hypertension by Transjugular Portosystemic Shunt Placement and Infliximab Treatment’, Case Reports in Gastroenterology, 10(3), pp. 589–595. Available at: https://doi.org/10.1159/000450541.
Li, Dalin et al. (2016) ‘A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn’s Disease and Human Gut Microbiome Composition’, Gastroenterology, 151(4), pp. 724–732. Available at: https://doi.org/10.1053/j.gastro.2016.06.051.
Li, Dalin et al. (2016) ‘A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn’s Disease and Human Gut Microbiome Composition’, Gastroenterology, 151(4), pp. 724–732. Available at: https://doi.org/10.1053/j.gastro.2016.06.051.
Rossini, Valerio et al. (2016) ‘Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells’, Journal of Visualized Experiments, (115), p. e54421. Available at: https://doi.org/10.3791/54421.
Rossini, Valerio et al. (2016) ‘Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells’, Journal of Visualized Experiments, (115), p. e54421. Available at: https://doi.org/10.3791/54421.
Steinert, Anna, Radulovic, Katarina and Niess, Jan (2016) ‘Gastro-intestinal tract: The leading role of mucosal immunity’, Swiss Medical Weekly, 146, p. w14293. Available at: https://doi.org/10.4414/smw.2016.14293.
Steinert, Anna, Radulovic, Katarina and Niess, Jan (2016) ‘Gastro-intestinal tract: The leading role of mucosal immunity’, Swiss Medical Weekly, 146, p. w14293. Available at: https://doi.org/10.4414/smw.2016.14293.
Radulovic, K. and Niess, J. H. (2015) ‘CD69 Is the Crucial Regulator of Intestinal Inflammation: A New Target Molecule for IBD Treatment?’, Journal of Immunology Research, 2015, p. 497056. Available at: https://doi.org/10.1155/2015/497056.
Radulovic, K. and Niess, J. H. (2015) ‘CD69 Is the Crucial Regulator of Intestinal Inflammation: A New Target Molecule for IBD Treatment?’, Journal of Immunology Research, 2015, p. 497056. Available at: https://doi.org/10.1155/2015/497056.
Niess, Jan Hendrik and Danese, Silvio (2014) ‘Anti-TNF and skin inflammation in IBD: a new paradox in gastroenterology?’, Gut, 63(4), pp. 533–5. Available at: https://doi.org/10.1136/gutjnl-2013-304683.
Niess, Jan Hendrik and Danese, Silvio (2014) ‘Anti-TNF and skin inflammation in IBD: a new paradox in gastroenterology?’, Gut, 63(4), pp. 533–5. Available at: https://doi.org/10.1136/gutjnl-2013-304683.
Rossini V et al. (2014) ‘CX3CR1 cells facilitate the activation of CD4 T cells in the colonic lamina propria during antigen-driven colitis’, Mucosal Immunology. 16.10.2013, 7(3), pp. 533–548. Available at: https://doi.org/10.1038/mi.2013.70.
Rossini V et al. (2014) ‘CX3CR1 cells facilitate the activation of CD4 T cells in the colonic lamina propria during antigen-driven colitis’, Mucosal Immunology. 16.10.2013, 7(3), pp. 533–548. Available at: https://doi.org/10.1038/mi.2013.70.
Schulz, O. et al. (2014) ‘Hypertrophy of infected Peyer’s patches arises from global, interferon-receptor, and CD69-independent shutdown of lymphocyte egress’, Mucosal Immunology, 7(4), pp. 892–904. Available at: https://doi.org/10.1038/mi.2013.105.
Schulz, O. et al. (2014) ‘Hypertrophy of infected Peyer’s patches arises from global, interferon-receptor, and CD69-independent shutdown of lymphocyte egress’, Mucosal Immunology, 7(4), pp. 892–904. Available at: https://doi.org/10.1038/mi.2013.105.
Radulovic K et al. (2013) ‘The Early Activation Marker CD69 Regulates the Expression of Chemokines and CD4 T Cell Accumulation in Intestine’, PLoS ONE. 12.06.2013, 8(6), p. e65413. Available at: https://doi.org/10.1371/journal.pone.0065413.
Radulovic K et al. (2013) ‘The Early Activation Marker CD69 Regulates the Expression of Chemokines and CD4 T Cell Accumulation in Intestine’, PLoS ONE. 12.06.2013, 8(6), p. e65413. Available at: https://doi.org/10.1371/journal.pone.0065413.
Neu C et al. (2013) ‘CD14-Dependent Monocyte Isolation Enhances Phagocytosis of Listeria monocytogenes by Proinflammatory, GM-CSF-Derived Macrophages’, PLoS ONE. 11.06.2013, 8(6), p. e66898. Available at: https://doi.org/10.1371/journal.pone.0066898.
Neu C et al. (2013) ‘CD14-Dependent Monocyte Isolation Enhances Phagocytosis of Listeria monocytogenes by Proinflammatory, GM-CSF-Derived Macrophages’, PLoS ONE. 11.06.2013, 8(6), p. e66898. Available at: https://doi.org/10.1371/journal.pone.0066898.
Posovszky C et al. (2013) ‘Age-of-onset-dependent influence of NOD2 gene variants on disease behaviour and treatment in Crohn’s disease’, BMC Gastroenterology. 02.05.2013, 13(1), p. 77. Available at: https://doi.org/10.1186/1471-230X-13-77.
Posovszky C et al. (2013) ‘Age-of-onset-dependent influence of NOD2 gene variants on disease behaviour and treatment in Crohn’s disease’, BMC Gastroenterology. 02.05.2013, 13(1), p. 77. Available at: https://doi.org/10.1186/1471-230X-13-77.
Manta C et al. (2013) ‘CX3CR1+ macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium’, Mucosal Immunology. 01.08.2012, 6(1), pp. 177–188. Available at: https://doi.org/10.1038/mi.2012.61.
Manta C et al. (2013) ‘CX3CR1+ macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium’, Mucosal Immunology. 01.08.2012, 6(1), pp. 177–188. Available at: https://doi.org/10.1038/mi.2012.61.
Fatima, Sabiha et al. (2003) ‘CD26-/DPP IV-Positive Lymphocytes in Murine Acute Experimental Colitis’, J Investig Allergol Clin Immunol., pp. 345–350. Available at: https://doi.org/10.1007/0-306-47920-6_41.
Fatima, Sabiha et al. (2003) ‘CD26-/DPP IV-Positive Lymphocytes in Murine Acute Experimental Colitis’, J Investig Allergol Clin Immunol., pp. 345–350. Available at: https://doi.org/10.1007/0-306-47920-6_41.